XXEC Inc. Takes $896.38 Million Position in Nordson Corporation $NDSN

XXEC Inc. purchased a new position in Nordson Corporation (NASDAQ:NDSN) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 257,208,657 shares of the industrial products company’s stock, valued at approximately $896,378,000. Nordson accounts for about 0.4% of XXEC Inc.’s investment portfolio, making the stock its 10th biggest position. XXEC Inc. owned about 461.63% of Nordson at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in NDSN. New York Life Investment Management LLC increased its position in shares of Nordson by 64.9% in the fourth quarter. New York Life Investment Management LLC now owns 12,041 shares of the industrial products company’s stock worth $2,895,000 after purchasing an additional 4,737 shares during the last quarter. UBS Group AG raised its stake in Nordson by 7.3% in the fourth quarter. UBS Group AG now owns 432,984 shares of the industrial products company’s stock valued at $104,102,000 after purchasing an additional 29,294 shares in the last quarter. Jackson Creek Investment Advisors LLC bought a new stake in Nordson during the fourth quarter valued at approximately $1,426,000. Jennison Associates LLC lifted its position in Nordson by 539.2% during the fourth quarter. Jennison Associates LLC now owns 252,353 shares of the industrial products company’s stock valued at $60,673,000 after purchasing an additional 212,876 shares during the last quarter. Finally, Reflection Asset Management purchased a new position in Nordson in the 4th quarter worth approximately $1,460,000. Hedge funds and other institutional investors own 72.11% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on NDSN shares. Wall Street Zen cut shares of Nordson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Oppenheimer upped their target price on shares of Nordson from $335.00 to $370.00 and gave the stock an “outperform” rating in a research report on Friday. Robert W. Baird increased their target price on Nordson from $328.00 to $351.00 and gave the company a “neutral” rating in a research note on Friday. DA Davidson restated a “buy” rating and set a $345.00 price target on shares of Nordson in a research report on Thursday. Finally, KeyCorp reaffirmed a “buy” rating on shares of Nordson in a research note on Thursday. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $326.57.

Trending Headlines about Nordson

Here are the key news stories impacting Nordson this week:

• Positive Sentiment: Strong Q3 beat and broad-based growth: Nordson reported adjusted earnings of $3.25 per share, above the $3.09 consensus and up from $2.73 a year earlier. Revenue reached $817.7 million, exceeding estimates of $779.5 million and increasing 10.3% year over year. Record sales across all segments, stronger orders and broad organic growth supported the results. NDSN Q3 Earnings Beat Estimates on Broad Organic Growth
• Positive Sentiment: Higher fiscal 2026 outlook: Management raised its outlook for the third time, forecasting fiscal 2026 sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00. Backlog reportedly increased 35%, reinforcing expectations for continued demand and earnings momentum. Nordson Forecasts Fiscal 2026 Sales and EPS
• Positive Sentiment: Analyst price-target increases: Oppenheimer raised its target from $335 to $370 and upgraded its view to “outperform.” Robert W. Baird lifted its target from $328 to $351 while maintaining a “neutral” rating. DA Davidson reaffirmed its “buy” rating with a $345 target. Analysts Boost Forecasts on Nordson
• Neutral Sentiment: New medical product: Nordson MEDICAL introduced its Divert ULTRA line of ultra-high-pressure stopcocks for demanding medical applications. The launch expands the product portfolio but was not accompanied by a specific financial impact. Nordson MEDICAL Introduces Divert ULTRA
• Negative Sentiment: Insider selling and valuation: Reported insider activity showed 46 sales and no purchases over the past six months, including sizable sales by senior executives. After the rally, Nordson trades at roughly 33.6 times earnings, leaving the stock vulnerable to profit-taking if growth or guidance momentum slows.

Nordson Trading Down 0.7%

NDSN stock opened at $332.24 on Friday. The company has a market capitalization of $18.51 billion, a PE ratio of 33.59, a price-to-earnings-growth ratio of 2.15 and a beta of 0.96. Nordson Corporation has a one year low of $220.06 and a one year high of $338.55. The company’s 50 day moving average price is $298.83 and its two-hundred day moving average price is $287.07. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.65 and a current ratio of 1.82.

Nordson (NASDAQ:NDSN) last announced its quarterly earnings data on Wednesday, August 19th. The industrial products company reported $3.25 earnings per share for the quarter, topping analysts’ consensus estimates of $3.09 by $0.16. Nordson had a net margin of 18.63% and a return on equity of 20.49%. The firm had revenue of $817.67 million during the quarter, compared to analyst estimates of $779.49 million. During the same period in the previous year, the business posted $2.73 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. As a group, analysts predict that Nordson Corporation will post 11.8 earnings per share for the current fiscal year.

Nordson Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, July 6th. Shareholders of record on Thursday, June 18th were paid a $0.82 dividend. The ex-dividend date of this dividend was Thursday, June 18th. This represents a $3.28 annualized dividend and a yield of 1.0%. Nordson’s payout ratio is currently 33.16%.

About Nordson

Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company’s portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson’s offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.

Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.